David Rosenbaum on Muck Rack

David Rosenbaum

  • Editor in Chief, The Bloom Group LLC
Boston
As seen in: MSN Canada, The New York Times, Wiley Online Library, Scientific American, Canadian Journal of Experimental Psychology, Salon, Financial Post, New York Law Journal, Dove Medical Press, Association for Psychological Science and
Covers:  the occasional fun randomness, small business
Doesn't Cover: gadgets, consumer
Editor, writer, novelist, father, husband, joker, friend.

Get in touch with David

Contact David, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

David Rosenbaum’s Journalist Portfolio

A CFO Questions Business Values

A CFO Questions Business Values

During the three years Barry Rowan served as CFO and treasurer of Nextel Partners, the company's market capit…

View article →

Articles

Review of the Patient Burden and Therapeutic Landscape of Irritable Bowel Syndrome with Constipation in the United States [Corrigendum]

|
By Michael Cline, David Rosenbaum, Susan Edelstein
| Dove Medical Press
Back to Journals » Clinical and Experimental Gastroenterology » Volume 19 Authors Sendzischew Shane MA, Ruddy J, Cline M, Rosenbaum DP, Edelstein S, Moshiree B Received 21 April 2026 Accepted for publication 21 April 2026 Published 2 June 2026 Volume 2026:19 618800 DOI https://doi.org/10.2147/CEG.S618800 Sendzischew Shane MA, Ruddy J, Cline M, Rosenbaum DP, Edelstein S, Moshiree B. Clin Exp Gastroenterol. 2024;17:227–253.
Open in Who Shared Issue with article?

Ontario Moves To Regulate Preferred Pharmacy Networks (PPNs)

|
By Timothy M. Squire, David Rosenbaum, Ingrid Vander Elst
| Mondaq
Fasken are most popular: within Law Department Performance topic(s) with Senior Company Executives, HR and Finance and Tax Executives in Canada with readers working within the Banking & Credit, Business & Consumer Services and Healthcare industries The government of Ontario has signaled its intention to formally regulate preferred pharmacy networks ("PPNs") in employer-sponsored drug benefit plans.
Open in Who Shared Issue with article?

Five Hundred Days and Still Counting

|
By David Rosenbaum
| The Jewish Link of New Jersey Verified
More than a year ago I published a letter in this paper sharing my outrage regarding the October 7, 2023 terrorist attack on Israel and its aftermath. I was outraged by the double standard and failure of the world to see the true victims of the massacre. Instead, the media portrayed Israel as the aggressor and Palestinians as victims. We have suffered through college protests and mob protests throughout New York and New Jersey, one even in my hometown.
Open in Who Shared Issue with article?
See all 83 licensed articles (86 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified